Sermorelin vs Tesamorelin
Updated July 21, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of Sermorelin and Tesamorelin (also searched as Tesamorelin vs Sermorelin) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
Sermorelin centers on muscle, while Tesamorelin leans toward metabolic. On indexed research, Sermorelin is ahead (Sermorelin: 3 studies, Human evidence; Tesamorelin: 3, Preclinical). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •Sermorelin is strongest for muscle; Tesamorelin for metabolic.
- •Evidence: Sermorelin Human evidence (3 studies) vs Tesamorelin Preclinical (3).
- •Check the FDA-approval status chips above before assuming a legal use pathway.
Effect profiles, overlaid
At a glance
GHRH Analog | Growth Hormone Releasing Hormone
GHRH Analog | Visceral Fat Reduction
Sermorelin vs Tesamorelin: side-by-side
| Metric | Sermorelin | Tesamorelin |
|---|---|---|
| Class | GH | GH |
| Regulatory status | Research use only | FDA-approved |
| Evidence grade | Human evidence | Preclinical |
| Studies indexed | 3 | 3 |
| Research level | Well Studied | FDA Approved |
| Strongest effect | Muscle & body comp | Metabolic & appetite |
| Healing & recovery | 3.0▲ | 1.0 |
| Muscle & body comp | 4.0▲ | 2.0 |
| Metabolic & appetite | 3.0 | 4.0▲ |
| Neuro & mood | 2.0▲ | 1.0 |
| Sleep & circadian | 2.0▲ | 0.0 |
| Inflammation & immune | 1.0▲ | 1.0▲ |
| Skin & aesthetics | 3.0▲ | 3.0▲ |
▲ marks the higher community effect score (0–5 perceived-effect signal, not clinical efficacy).
Mechanism & pharmacokinetics
| Property | Sermorelin | Tesamorelin |
|---|---|---|
| Mechanism | GHRH (1–29) analog | GHRH analog |
| Route | Subcutaneous injection | Subcutaneous injection |
| Half-life | — | ~26–38 min |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is Sermorelin?
### Summary Sermorelin is a synthetic peptide that mimics growth hormone-releasing hormone (GHRH), stimulating the pituitary gland to produce and release endogenous growth hormone. It has been investigated for its potential therapeutic applications, particularly in the context of growth hormone deficiencies and other related conditions.
Full Sermorelin profile, mechanism & studies →What is Tesamorelin?
### Tesamorelin Summary Tesamorelin is a synthetic peptide that functions as a growth hormone-releasing hormone (GHRH) analog, primarily investigated for its potential to reduce visceral fat in individuals with HIV-associated lipodystrophy. Its role in metabolic health and body composition continues to be explored in various clinical contexts.
Full Tesamorelin profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | Sermorelin | 3.0/5 effect signal |
| Muscle | Sermorelin | 4.0/5 effect signal |
| Metabolic | Tesamorelin | 4.0/5 effect signal |
| Neuro | Sermorelin | 2.0/5 effect signal |
| Sleep | Sermorelin | 2.0/5 effect signal |
| Inflammation | Even | Both ~1.0/5 |
| Skin | Even | Both ~3.0/5 |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack Sermorelin and Tesamorelin?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because at least one is a research-use compound, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
Sermorelin vs Tesamorelin: side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
Sermorelin has 3 approved studies indexed (Human evidence), and Tesamorelin has 3 (Preclinical). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is Sermorelin or Tesamorelin better?
It depends on your goal. Sermorelin is strongest for muscle; Tesamorelin for metabolic. Sermorelin has more indexed studies (3). See the goal-by-goal breakdown above.
Is Sermorelin or Tesamorelin better for weight loss?
Tesamorelin shows the stronger metabolic & appetite profile (4.0/5) in community effect data — though weight-loss outcomes depend on the individual and the evidence base.
Is Sermorelin or Tesamorelin better for muscle?
Sermorelin leads on the muscle & body-composition axis (4.0/5).
Which has more research, Sermorelin or Tesamorelin?
Sermorelin has 3 approved studies indexed (Human evidence); Tesamorelin has 3 (Preclinical). Higher counts mean more to read, not proven superiority.
Can you stack Sermorelin and Tesamorelin?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of Sermorelin vs Tesamorelin?
Sermorelin: no community-reported effects logged yet. Tesamorelin: none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is Sermorelin or Tesamorelin FDA-approved?
Sermorelin is a research-use compound and is not FDA-approved. Tesamorelin is FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is Tesamorelin better than Sermorelin?
For metabolic, Tesamorelin has the edge; for muscle, Sermorelin does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
Approval status varies (see the chips at the top). FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed July 21, 2026.